查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1977708

全球愛迪生氏症檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Addison Disease Testing Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 121 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計愛迪生氏症檢測市場將從 2025 年的 2.8519 億美元成長到 2034 年的 3.9757 億美元，2026 年至 2034 年的複合年成長率為 3.76%。

由於人們對腎上腺疾病的認知不斷提高，以及早期診斷的重要性日益凸顯，全球愛迪生氏症檢測市場正經歷穩定成長。準確的荷爾蒙檢測，即測量皮質醇和促腎上腺皮質激素（ACTH）水平，對於診斷愛迪生氏症至關重要。自體免疫疾病的日益增加以及醫療保健服務的改善，都推動了對診斷解決方案的需求。發展中地區檢測基礎設施的擴建也進一步促進了市場成長。

關鍵成長要素包括免疫檢測技術的進步和自動化診斷平台的日益普及。醫療機構正致力於早期檢測，以預防嚴重併發症。內分泌疾病研究經費的增加也促進了市場擴張。此外，患者對相關症狀的認知提高以及定期體檢的廣泛普及也推動了這些檢測方法的應用。

展望未來，隨著就地檢驗的進步和檢測系統的數位整合，市場有望進一步受益。新興市場對診斷服務的投資將創造新的機會。各公司正致力於開發高靈敏度和具成本效益的檢測套組。隨著全球對內分泌健康意識的不斷提高，全球愛迪生氏症檢測市場預計將穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球愛迪生氏症檢測市場：依檢測類型分類

  • 市場分析、洞察與預測
  • 實驗室血液檢測
  • 綜合代謝指標
  • 甲狀腺刺激素（TSH）水平
  • ACTH刺激試驗
  • 胰島素誘發的低血糖症
  • 自體抗體
  • 催乳素
  • 影像檢查
  • 胸部X光相片
  • 電腦斷層掃描（CT）
  • 血清皮質醇檢測

第5章：全球愛迪生氏症檢測市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 診所
  • 診斷檢查室

第6章：全球愛迪生氏症檢測市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Thermo Fisher Scientific
    • Roche Diagnostics
    • Siemens Healthineers
    • DiaSorin SPA
    • Beckman Coulter
    • Abbott Laboratories
    • Bio-Rad Laboratories
    • Fuji Rebio Diagnostics
    • Randox Laboratories
    • Nova Biomedical
簡介目錄
Product Code: VMR112112832

The Addison Disease Testing Market size is expected to reach USD 397.57 Million in 2034 from USD 285.19 Million (2025) growing at a CAGR of 3.76% during 2026-2034.

The Global Addison Disease Testing Market is experiencing steady growth due to increasing awareness of adrenal disorders and early diagnosis. Addison's disease requires accurate hormonal testing to measure cortisol and ACTH levels. Rising prevalence of autoimmune conditions and improved healthcare access are supporting demand for diagnostic solutions. Expanding laboratory infrastructure in developing regions is further contributing to market growth.

Key growth drivers include advancements in immunoassay technologies and growing adoption of automated diagnostic platforms. Healthcare providers are focusing on early detection to prevent severe complications. Increasing research funding for endocrine disorders is also strengthening market expansion. Additionally, improved patient awareness about symptoms and routine health check-ups are encouraging testing adoption.

Looking ahead, the market is expected to benefit from improved point-of-care testing and digital integration of laboratory systems. Emerging markets investing in diagnostic services will create additional opportunities. Companies are focusing on high-sensitivity and cost-effective test kits. As endocrine health awareness increases globally, the Global Addison Disease Testing Market is projected to grow steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test Type

  • Laboratory
  • Comprehensive Metabolic Panel
  • Thyroid-Stimulating Hormone (TSH) Levels
  • ACTH Stimulation
  • Insulin-induced Hypoglycaemia
  • Autoantibody
  • Prolactin
  • Imaging Studies
  • Chest Radiograph
  • Computed Tomography (CT) Scan
  • Serum Cortisol Testing

By End User

  • Hospitals
  • Clinics
  • Diagnostics Laboratories

COMPANIES PROFILED

  • Thermo Fisher Scientific, Roche Diagnostics, Siemens Healthineers, DiaSorin SpA, Beckman Coulter, Abbott Laboratories, BioRad Laboratories, Fuji Rebio Diagnostics, Randox Laboratories, Nova Biomedical
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ADDISON DISEASE TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Test Type
  • 4.2. Laboratory Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Comprehensive Metabolic Panel Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Thyroid-Stimulating Hormone (TSH) Levels Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. ACTH Stimulation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Insulin-induced Hypoglycaemia Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Autoantibody Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.8. Prolactin Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.9. Imaging Studies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.10. Chest Radiograph Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.11. Computed Tomography (CT) Scan Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.12. Serum Cortisol Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ADDISON DISEASE TESTING MARKET: BY END USER 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End User
  • 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Diagnostics Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ADDISON DISEASE TESTING MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Test Type
    • 6.2.2 By End User
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Test Type
    • 6.3.2 By End User
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Test Type
    • 6.4.2 By End User
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Test Type
    • 6.5.2 By End User
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Test Type
    • 6.6.2 By End User
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL ADDISON DISEASE TESTING INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Thermo Fisher Scientific
    • 8.2.2 Roche Diagnostics
    • 8.2.3 Siemens Healthineers
    • 8.2.4 DiaSorin S.P.A
    • 8.2.5 Beckman Coulter
    • 8.2.6 Abbott Laboratories
    • 8.2.7 Bio-Rad Laboratories
    • 8.2.8 Fuji Rebio Diagnostics
    • 8.2.9 Randox Laboratories
    • 8.2.10 Nova Biomedical